The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2026
Filed:
Mar. 27, 2020
Applicants:
Societe Des Produits Nestle S.a., Vevey, CH;
Ludwig Institute for Cancer Research Ltd, Zurich, CH;
Inventors:
Nicola Vannini, La Croix, CH;
George Coukos, Chexbres, CH;
Serge Andre Dominique Rezzi, Semsales, CH;
Julie Laval, Caux, FR;
Caroline Monnard, Cheseaux-sur-Lausanne, CH;
Marcela Rincon Restrepo, Lausanne, CH;
Assignees:
SOCIETE DES PRODUITS NESTLE S.A., Vevey, CH;
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD, Zurich, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/37 (2006.01); A61K 31/198 (2006.01); A61K 31/706 (2006.01); A61K 31/714 (2006.01); A61K 40/11 (2025.01); A61K 40/45 (2025.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 31/37 (2013.01); A61K 31/198 (2013.01); A61K 31/706 (2013.01); A61K 31/714 (2013.01); A61K 40/11 (2025.01); A61K 40/45 (2025.01); C12N 5/0636 (2013.01); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); C12N 2500/32 (2013.01); C12N 2500/38 (2013.01); C12N 2500/40 (2013.01);
Abstract
An agent for use in reducing T cell exhaustion and/or increasing T cell function, and/or boosting immunity, wherein the agent is selected from the group consisting of nicotinamide riboside, vitamin B12, a urolithin, manganese, serine, glycine, arginine, asparagine, and a combination of two or more thereof.